These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
15. Halofuginone, a specific inhibitor of collagen type 1 synthesis, ameliorates oxidant colonic damage in rats with experimental colitis. Karakoyun B, Yüksel M, Ercan F, Salva E, Işik I, Yeğen BC. Dig Dis Sci; 2010 Mar; 55(3):607-16. PubMed ID: 19390970 [Abstract] [Full Text] [Related]
18. Fibrosis inhibition and muscle histopathology improvement in laminin-alpha2-deficient mice. Nevo Y, Halevy O, Genin O, Moshe I, Turgeman T, Harel M, Biton E, Reif S, Pines M. Muscle Nerve; 2010 Aug; 42(2):218-29. PubMed ID: 20589893 [Abstract] [Full Text] [Related]
19. Response of an ovine laryngeal injury model to a novel fibrosis inhibitor. Allen J. ANZ J Surg; 2017 Apr; 87(4):266-270. PubMed ID: 27878913 [Abstract] [Full Text] [Related]
20. The effects of methylprednisolone and halofuginone on preventing esophageal and hypopharyngeal fibrosis in delivered radiotherapy. Dabak H, Karlidag T, Akpolat N, Keles E, Alpay HC, Serin M, Kaygusuz I, Yalcin S, Isik O. Eur Arch Otorhinolaryngol; 2010 Sep; 267(9):1429-35. PubMed ID: 20364346 [Abstract] [Full Text] [Related] Page: [Next] [New Search]